4/25
11:01 am
nxl
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements [Yahoo! Finance]
Low
Report
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements [Yahoo! Finance]
4/25
10:44 am
nxl
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
Low
Report
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
4/10
08:43 am
nxl
Nexalin Technology CEO Provides Letter to Shareholders [Yahoo! Finance]
Medium
Report
Nexalin Technology CEO Provides Letter to Shareholders [Yahoo! Finance]
4/10
08:30 am
nxl
Nexalin Technology CEO Provides Letter to Shareholders
Low
Report
Nexalin Technology CEO Provides Letter to Shareholders
4/9
10:03 am
nxl
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers [Seeking Alpha]
Medium
Report
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers [Seeking Alpha]
4/9
08:37 am
nxl
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing [Yahoo! Finance]
Low
Report
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing [Yahoo! Finance]
4/9
08:30 am
nxl
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
Low
Report
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
4/4
01:19 pm
nxl
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device [Yahoo! Finance]
Medium
Report
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device [Yahoo! Finance]
4/4
01:00 pm
nxl
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
Low
Report
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
4/4
11:13 am
nxl
Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device [Yahoo! Finance]
High
Report
Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device [Yahoo! Finance]
4/2
08:39 am
nxl
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board [Yahoo! Finance]
High
Report
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board [Yahoo! Finance]
4/2
08:30 am
nxl
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
High
Report
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
3/30
09:01 am
nxl
Nexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022) [Yahoo! Finance]
High
Report
Nexalin Technology Full Year 2023 Earnings: US$0.63 loss per share (vs US$0.30 loss in FY 2022) [Yahoo! Finance]
3/28
08:40 am
nxl
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego [Yahoo! Finance]
High
Report
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego [Yahoo! Finance]
3/28
08:30 am
nxl
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
High
Report
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
3/14
08:54 am
nxl
Nexalin Technology commences sales of gen-2 neurostimulation device in Oman [Seeking Alpha]
High
Report
Nexalin Technology commences sales of gen-2 neurostimulation device in Oman [Seeking Alpha]
3/14
08:51 am
nxl
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology [Yahoo! Finance]
High
Report
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology [Yahoo! Finance]
3/14
08:30 am
nxl
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
High
Report
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
3/13
08:30 am
nxl
Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
Medium
Report
Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
3/6
08:51 am
nxl
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia [Yahoo! Finance]
High
Report
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia [Yahoo! Finance]
3/6
08:30 am
nxl
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
High
Report
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
2/8
08:51 am
nxl
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device [Yahoo! Finance]
High
Report
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device [Yahoo! Finance]
2/8
08:30 am
nxl
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
High
Report
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device